메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

전체기사

AB Electrolux publishes 2025 Annual Report

STOCKHOLM, Feb. 19, 2026 -- AB Electrolux Annual Report for 2025 has been published on the Group's website as of today. Highlights of the 2025 Annual Report The Group achieved organic sales growth of 3.9%, driven primarily by North America and Latin America. Operating income improved to SEK 3.7bn with an operating margin of 2.8% despite heavy headwinds from tariffs and currency. Cost efficiency contributed with SEK 4.0bn to earnings for the Group, as good progress was made on delivering product cost reductions. A new vision was launch
- 황정호 기자
- 2026-02-19 17:45
CUBE ACQUIRES SILICON VALLEY REGTECH, 4CRISK, DELIVERING NEXT GENERATION COMPLIANCE AND RISK MAPPING AUTOMATION

Key highlights: Purpose-built, proven and trusted AI maps regulatory obligations directly to controls, policies, procedures and risks Expands CUBE's leadership in financial regulation into adjacent corporate regulatory domains Furthers CUBE's capabilities to serve customers with a unified, AI-first, enterprise wide compliance and risk platform LONDON, Feb. 19, 2026 -- CUBE, a global leader in Automated Regulatory Intelligence (ARI) and Regulatory Change Management (RCM), announces the acquisition of 4CRisk.ai (4CRisk), a Silicon Valley headquartered RegTech busi
- 황정호 기자
- 2026-02-19 16:00
Marina Bay precinct partners UOB, Marina Bay Sands and Singapore Tourism Board, together with Disney Cruise Line, to illuminate Singapore's skyline with a fireworks sky show

With continued support from Bay partners, the third edition of the Marina Bay Precinct Partnership will feature nautical-themed festivities across two months with Disney Cruise Line-themed photo spots and additional special privileges for UOB customers at the Bay area. SINGAPORE, Feb. 19, 2026 -- Marina Bay precinct partners UOB, Marina Bay Sands, and Singapore Tourism Board (STB), together with Disney Cruise Line, will present a sky show that lights up the Singapore skyline over three nights from 13 to 15 March 2026. This will be a key highlight of the two-month long nautical-
- 김장윤(JASON KIM) 기자
- 2026-02-19 14:30
Mastercard unveils Inclusion Hub and innovative inclusivity measures co-designed with autistic Australians

[ 메디채널 황정호 기자 ] Available now, businesses can sign up to Mastercard's Inclusion Hub which features 25 practical measures for venues to adapt, including Sensory Notes, which was piloted at this year's Australian Open and continues to be activated with Melbourne's The Mulberry Group SYDNEY, Feb. 19, 2026 -- One in 40 Australians are autistici, yet many everyday spaces aren't designed with their needs in mind. Sensory overload, unpredictable environments, and lack of clarity can make routine activities inaccessible, limiting where autistic Australians and their caregivers feel comfortab
- 황정호 기자
- 2026-02-19 11:51
Varaha Launches Varaha Industrial Partners Program (VIPP) to Scale Industrial Biochar Carbon Removal in Côte d'Ivoire

GURUGRAM, India, Feb. 19, 2026 -- Varaha is launching the Varaha Industrial Partners Program (VIPP), a global initiative that enables biomass processing facilities with access to sustainable biomass feedstocks to generate high-integrity carbon removal credits using Varaha's digital MRV and commercialization platforms. As the first VIPP launch partnership, Varaha will work with Revata Carbon and Valency International to develop an industrial biochar carbon removal project in Côte d'Ivoire. Côte d'Ivoire is a major hub in the global cashew economy. As the cash
- 황정호 기자
- 2026-02-19 11:45
Yiwu in the Year of the Horse: Understanding the Chinese Expression of a "Global Community"

YIWU, China, Feb. 19, 2026 -- A news report from Yiwu Media Convergence Center: When Jackie Chan and Lionel Richie joined hands on the 2026 Spring Festival Gala stage to sing "We are the World", the melody crossed mountains and seas, landing in the vibrant land of Yiwu. The eight-minute presentation at the Yiwu sub-venue not only became a highlight of the Year of the Horse Gala but also brought the image of "World's Yiwu" into the global spotlight. Behind the Global Attention Lies Solid Development Foundation Data shows that in 2025, Yiwu's to
- 김장윤(JASON KIM) 기자
- 2026-02-19 11:15
FDA, 치명적 약제내성 병원체 표적 신속 검사 2종을 혁신 의료기기로 지정

산타마리아, 캘리포니아 및 기프리, 프랑스 , 2026년 2월 19일 -- 엔지 바이오텍(NG Biotech)과 하디 다이애그노스틱스(Hardy Diagnostics)가 항생제 내성(Antimicrobial Resistance, AMR)에 대응하는 중대한 진전을 이룬 가운데 미국 식품의약국(Food and Drug Administration, FDA)에서 두 가지 신속 진단 분석법 NG-TEST®Candida auris와 NG-TEST®Acineto-5®을 혁신 의료기기로 지정했다고 2월 18일 발표했다. 이 지정은 생명을 위협하는 질환 및 중대한 미충족 의료 수요를 해결할 잠재력을 지닌 기술을 대상으로 하는 것이다. 두 검사는 모두 세계보건기구(World Health Organization, WHO)에서 최우선으로 분류한 병원체가 대상이다. 칸디다 아우리스(Candida auris)는 WHO 진균 우선순위 병원체 목록(Fungal Priority Pathogens List 2022)에 등재된 다제내성 효모로, 전 세계 병원 내 집단감염의 원인이 되고 있으며 검출이 어렵고 높은 사망률과 연관이 있다. 카바페
- 김갑성 기자
- 2026-02-19 10:31
Financial AI Leaders Join Forces: BridgeWise Acquires US-Based Context Analytics to Pioneer End-to-End Wealth-Native Intelligence

[ 메디채널 황정호 기자 ] The acquisition combines institutional AI and alternative data processing to deliver the industry's first fully integrated wealth intelligence solution. NEW YORK, Feb. 19, 2026 -- BridgeWise, the global leader in AI for wealth, today announced the acquisition of Chicago-based Context Analytics, the top AI-powered alternative data processing company, used by tier-one financial firms including S&P Global Market Intelligence. By merging BridgeWise's institutional-grade investment intelligence platform – already embedded in financial institutions across Asia, E
- 황정호 기자
- 2026-02-19 07:00
A World-First in Neonatal Care: Japan Approves Prolacta Bioscience's 100% Human Milk-Based Fortifiers as a Prescription Drug for Vulnerable Infants

Japan's Ministry of Health, Labour and Welfare (MHLW) Approves PreemieFort® Enteral Solution as Prescription Medicine in the NICU DUARTE, Calif., Feb. 19, 2026 -- Prolacta Bioscience® today announced that Japan's Ministry of Health, Labour and Welfare (MHLW) has approved PreemieFort® Enteral Solution, a 100% human milk-based fortifier, as a prescription drug for very low birth weight infants, infants with congenital gastrointestinal disorders or congenital heart diseases, and those recovering from gastrointestinal surgery. This regulatory milestone was achieved in
- 김갑성 기자
- 2026-02-19 05:03
Lifespan Vision Ventures Co-Leads Sift Biosciences' $3.7M Pre-Seed Financing

NORWALK, Conn., Feb. 19, 2026 -- Lifespan Vision Ventures, an investment firm focused on therapeutics that improve human healthspan, today announced that it has co-led Sift Biosciences' oversubscribed $3.7 million Pre-Seed financing alongside Freeflow Ventures, with participation from Valuence Ventures, Eisai Innovation, SBI US Gateway Fund, and other early investors. Sift Biosciences is developing a peptide-based immunotherapy platform designed to harness pre-existing immune memory. The company's approach aims to generate more consistent immune engagement by activating memory
- 김갑성 기자
- 2026-02-19 01:00

이전

21 22 23 24 25 26 27 28 29 30

많이 본 기사

최근기사

2026-03-02_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2026년 03월 02일 18시 40분